Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases

被引:0
作者
Aaron Kaplan
Min Jun Li
Rachna Malani
机构
[1] Weill Cornell Medicine,Department of Neurology
[2] Memorial Sloan Kettering Cancer Center,Department of Neurology
[3] MSKCC Human Oncology and Pathogenesis Program,undefined
[4] Memorial Sloan Kettering Cancer Center,undefined
来源
Current Oncology Reports | 2022年 / 24卷
关键词
Breast Cancer; Brain metastases; Leptomeningeal metastases; Radiation therapy; Intrathecal treatment; Systemic treatment; Immunotherapy; CAR-T; Blood–brain-barrier;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:343 / 350
页数:7
相关论文
共 382 条
[1]  
Martin AM(2017)Brain metastases in newly diagnosed breast cancer: a population-based study JAMA Oncol 3 1069-1077
[2]  
Cagney DN(2012)Brain metastases free survival differs between breast cancer subtypes Br J Cancer 106 440-446
[3]  
Catalano PJ(2010)Survival of breast cancer patients with meningeal carcinomatosis Ann Oncol 21 2183-2187
[4]  
Warren LE(2017)EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours Ann Oncol 28 iv84-99
[5]  
Bellon JR(2018)Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM) J Neurooncol 138 191-198
[6]  
Punglia RS(2009)Human epidermal growth factor receptor 2–positive breast cancer and central nervous system metastases J Clin Oncol 27 5278-5286
[7]  
Berghoff A(2013)The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer J Neurooncol 112 467-472
[8]  
Bago-Horvath Z(2016)Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid J Clin Oncol Off J Am Soc Clin Oncol 34 2404-2415
[9]  
De Vries C(2020)Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer J Neurooncol 148 599-606
[10]  
Dubsky P(2016)Integration of breast cancer secretomes with clinical data elucidates potential serum markers for disease detection, diagnosis, and prognosis PLoS One 11 e0158296-2305